Market Overview

ICYMI: Valeant, Overstock And Biotechs

Share:
Related GRPN
Groupon, IBM Settle Patent Lawsuits In $57M Deal
Benzinga's Top Upgrades, Downgrades For September 14, 2018
Blue Apron: The Oven Is Now On Fire (Seeking Alpha)
Related REGN
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs
FDA OKs Regeneron and Sanofi's Dupixent for asthma (Seeking Alpha)

In case you missed it, here are some of Benzinga's top stories from Monday, March 5, 2018.

A Valeant Bear Relents

Learn what finally convinced Deutsche Bank’s Gregg Gilbert to grant a buy rating to Valeant Pharmaceuticals Inc (NYSE: VRX) in Elizabeth Balboa’s “How Valeant Finally Won Over A Longtime Bear.”

Overstock Bull Sharpens His Horns Ahead Of ICO

Despite last week’s SEC scare, Overstock.com Inc (NASDAQ: OSTK) is still a hot stock with plenty of upside, according to D.A. Davidson. Get some background on this bull’s thesis in Wayne Duggan’s “Analyst Stays Bullish On Overstock's tZERO Coin Offering Despite Regulatory Risk.”

Related Link: Morgan Stanley Says Groupon's 16% Decline In 2018 Is 'Overdone'

Keep Your Eyes Peeled For These 7 Biotechs In March

From Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to ImmunoGen, Inc (NASDAQ: IMGN), several biotechs are expected to release meaningful updates on their clinical programs this month. Shanthi Rexaline has the details.

Latest Ratings for GRPN

DateFirmActionFromTo
Sep 2018WedbushInitiates Coverage OnNeutral
Jul 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
May 2018UBSUpgradesSellNeutral

View More Analyst Ratings for GRPN
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Cryptocurrency News Previews After-Hours Center Markets Analyst Ratings

 

Related Articles (IMGN + GRPN)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ETTXWedbushInitiates Coverage On19.0
WINGWedbushDowngrades0.0
BMYCitigroupDowngrades57.0
INTCNomuraUpgrades0.0
HRZNKeefe Bruyette & WoodsDowngrades10.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPS And Ryder Are In Strong Bearish Trends

8 Stocks Moving In Monday's After-Hours Session